Pregled bibliografske jedinice broj: 505156
The role of proteomics in plasma fractionation and quality control of plasma-derived therapeutic proteins
The role of proteomics in plasma fractionation and quality control of plasma-derived therapeutic proteins // Blood Transfusion, 8 (2010), 3; 86-91 doi:10.2450/2010.014S (međunarodna recenzija, pregledni rad, znanstveni)
CROSBI ID: 505156 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
The role of proteomics in plasma fractionation and
quality control of plasma-derived therapeutic
proteins
Autori
Gašo-Sokač, Dajana ; Djuro, Josić
Izvornik
Blood Transfusion (1723-2007) 8
(2010), 3;
86-91
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, pregledni rad, znanstveni
Ključne riječi
proteomics ; quality control ; plasma fractionation ; Factor VIII
Sažetak
After a relatively slow start, proteomics has finally progressed into different branches of transfusion Medicine. Proteomic technologies can be used as an efficient tool for process development and characterization of human plasma- derived therapeutic proteins. Proteomics can be used for process validation and quality control of these therapeutic proteins. It has been demonstrated that proteomics also offer fast and efficient ways for the identification of potentially harmful impurities. After their identification, the time for process optimization towards their removal can be significantly shortened.
Izvorni jezik
Engleski
Znanstvena područja
Kemija, Biologija
POVEZANOST RADA
Ustanove:
Prehrambeno-tehnološki fakultet, Osijek
Citiraj ovu publikaciju:
Časopis indeksira:
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE
